Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugo is a precisely targeted small molecule MEK inhibitor with a therapeutic focus on targeted therapies targeting specific tumor types, especially in the treatment of neurofib···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：373
Koselugo is a class of precision small molecule MEK inhibitors (also regarded as schizogenic activation antagonists), and its core efficacy focuses on targeted therapy for specific···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：361
Koselugo is a small molecule MEK inhibitor (figogen activation inhibitor) that is mainly used for the treatment of certain types of tumors, especially in the treatment of neurofibr···【more】
Article source：Captain MedicineRelease date：2024-08-22Recommended：369
Anamorelin is a drug for cancer cachexia that increases a patient's appetite and weight by mimicking the effects of ghrelin. This drug can significantly improve the nutritional···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：455
As a selective ghrelin receptor agonist, anamolin is approved in Japan for improving the health of cancer cachexia patients. By promoting appetite and gaining weight, it has a posi···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：320
Through its unique pharmacological effects, Anamoreline is effective in helping cancer patients overcome weight loss and loss of appetite. Drugs have shown therapeutic potential in···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：290
Anamorelin helps cancer patients with dyscrasia restore the body's energy supply by stimulating appetite and increasing growth hormone secretion. It is currently the only widel···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：347
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by various cancers such as non-small cell lung cancer. The drug has performed well in multiple clinical tria···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：412
Anamorelin is a novel ghrelin receptor agonist specifically designed for the treatment of cancer cachexia. It provides vital support to patients with advanced cancer by increasing ···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：453
Anamorelin is a selective oral medication that increases a patient's appetite and body weight primarily by activating ghrelin receptors. It is especially suitable for cancer pa···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：364
Anamorelin is a ghrelin receptor agonist that is effective in improving appetite and muscle mass in patients with cancer cachexia. Drugs have shown good results in clinical trials,···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：453
Anamorelin, the world's first oral drug specifically for the treatment of cancer cachexia, was launched by Ono Pharmaceutical of Japan in 2021. It helps patients regain their a···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：379
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
